Naltreksonklorid Amomed (Naltrexone Hydrochloride)

Naltrexone Hydrochloride, the active ingredient in Naltreksonklorid Amomed, is an opioid antagonist presented as an oral dosage form for oral use. It is employed in the management of alcohol dependence and opioid dependence after detoxification. GNH USA supplies Naltreksonklorid Amomed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naltrexone Hydrochloride is used to treat disorders related to opioid and alcohol dependence. - Alcohol dependence: reduces cravings and supports maintenance of abstinence. - Opioid dependence (post‑detoxification): blocks opioid receptors to prevent relapse. - Prevention of relapse in opioid dependence: maintains opioid‑free state after initial withdrawal.

Naltrexone Hydrochloride may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: occasional tension‑type headache. - Dizziness: transient light‑headedness. - Fatigue: feeling of tiredness. - Insomnia: difficulty falling or staying asleep. - Gastrointestinal discomfort: abdominal cramping or diarrhea.

Serious or Rare Side Effects: - Hepatotoxicity: elevated liver enzymes or liver injury. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Depression or suicidal thoughts: mood changes requiring immediate medical attention. - Hypotension: marked drop in blood pressure. - Seizures: rare convulsive episodes. - Acute withdrawal syndrome: precipitated opioid withdrawal in dependent individuals.

Before initiating therapy with Naltrexone Hydrochloride, consider the following precautions. - Liver function assessment: evaluate baseline hepatic enzymes, especially in patients with liver disease. - Opioid withdrawal risk: ensure the patient is opioid‑free for at least 7‑10 days to avoid precipitated withdrawal. - Pregnancy and lactation: use only if the potential benefit justifies the potential risk, as safety data are limited. - Concomitant CNS depressants: monitor for additive sedation or respiratory depression. - Renal impairment: adjust monitoring in patients with severe kidney disease. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and direct sunlight.

Naltrexone Hydrochloride can interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Opioid agonists (e.g., morphine, oxycodone): may precipitate acute withdrawal. - Hepatotoxic drugs (e.g., isoniazid, methotrexate): increase risk of liver injury.

Moderate Interactions (Monitor Closely): - Disulfiram: combined effect on alcohol aversion may intensify adverse reactions. - Benzodiazepines: additive central nervous system depression. - Antidepressants (SSRIs, SNRIs): monitor for mood changes. - Antihypertensives: possible additive hypotensive effect. - Immunosuppressants: monitor liver function and drug levels.